Clay B. Siegall

2010

In 2010, Clay B. Siegall earned a total compensation of $3.2M as President and CEO at Seattle Genetics, a 27% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$472,500
Option Awards$2,109,258
Salary$627,696
Other$7,890
Total$3,217,344

Siegall received $2.1M in option awards, accounting for 66% of the total pay in 2010.

Siegall also received $472.5K in non-equity incentive plan, $627.7K in salary and $7.9K in other compensation.

Rankings

In 2010, Clay B. Siegall's compensation ranked 1,831st out of 10,439 executives tracked by ExecPay. In other words, Siegall earned more than 82.5% of executives.

ClassificationRankingPercentile
All
1,831
out of 10,439
83rd
Division
Manufacturing
646
out of 3,838
83rd
Major group
Chemicals And Allied Products
122
out of 921
87th
Industry group
Drugs
69
out of 680
90th
Industry
Biological Products, Except Diagnostic Substances
13
out of 142
91st
Source: SEC filing on April 8, 2013.

Siegall's colleagues

We found five more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2010.

2010

Thomas Reynolds

Seattle Genetics

Chief Medical Officer

2010

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2010

Bruce Seeley

Seattle Genetics

EVP, Commercial

2010

Todd Simpson

Seattle Genetics

Chief Financial Officer

2010

Morris Rosenberg

Seattle Genetics

EVP, Process Sciences

News

In-depth

You may also like